Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.33 SEK | +1.84% | -0.45% | -23.34% |
14/02 | Sprint Bioscience AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
14/02 | Sprint Bioscience AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Sales 2024 * | 118M 10.76M 898M | Sales 2025 * | 199M 18.15M 1.52B | Capitalization | 92.86M 8.47M 707M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 0.04 x |
Net cash position 2024 * | 88.2M 8.05M 671M | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.47 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 28 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 47.2% |
1 day | +1.84% | ||
1 week | -0.45% | ||
Current month | +29.13% | ||
1 month | +29.13% | ||
3 months | +26.67% | ||
6 months | -28.88% | ||
Current year | -23.34% |
Managers | Title | Age | Since |
---|---|---|---|
Johan Emilsson
CEO | Chief Executive Officer | 40 | 01/23/01 |
Martin Andersson
FOU | Founder | 53 | 01/09/01 |
Director of Finance/CFO | 51 | 01/11/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 01/20/01 | |
Chairman | 56 | 01/21/01 | |
Fredrik Lehmann
BRD | Director/Board Member | 48 | 01/19/01 |
Date | Price | Change | Volume |
---|---|---|---|
30/24/30 | 1.33 | +1.84% | 17,205 |
29/24/29 | 1.306 | +1.24% | 157,957 |
26/24/26 | 1.29 | -4.16% | 178,498 |
25/24/25 | 1.346 | -1.03% | 96,321 |
24/24/24 | 1.36 | +4.78% | 46,579 |
Delayed Quote Nasdaq Stockholm, April 30, 2024 at 12:54 pm IST
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.34% | 8.45M | |
-1.17% | 102B | |
+2.87% | 96.09B | |
+2.13% | 22.28B | |
-14.77% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.21% | 16.09B | |
+8.55% | 13.83B | |
+35.75% | 11.97B |
- Stock Market
- Equities
- SPRINT Stock